secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coherus Oncology, Inc. (CHRS)
CIK:        0001512762
Form:       8-K
Filed at:   2024-01-10T23:59:59+00:00
Accession:  0001558370-24-000166
Event type: earnings
Sentiment:  neutral
Materiality: 0.30
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Coherus presents preliminary unaudited FY2023 revenue at JPM conference; no specifics in filing
--------------------------------------------------------------------------------

- Preliminary unaudited FY2023 revenue presented at 42nd Annual J.P. Morgan Healthcare Conference.
- Financial closing procedures not yet complete; final results may materially differ.
- Independent registered public accounting firm has not reviewed the preliminary data.
- Filing includes cautionary note about the preliminary nature of the results.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1512762/000155837024000166/0001558370-24-000166-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1512762/000155837024000166/chrs-20240110x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-000166

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer